Report overview
Lancing device is an instrument equipped with a lancet. It is also most commonly used by?diabetics?during?blood glucose monitoring. The depth of skin penetration can be adjusted for various skin thicknesses. Long lancing devices are used for?fetal scalp blood testing?to get a measure of the?acid base status?of the fetus.
This report contains market size and forecasts of Blood Glucose Monitoring Lancing Device in global, including the following market information:
Global Blood Glucose Monitoring Lancing Device Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Blood Glucose Monitoring Lancing Device Market Sales, 2018-2023, 2023-2030, (Units)
Global top five Blood Glucose Monitoring Lancing Device companies in 2022 (%)
The global Blood Glucose Monitoring Lancing Device market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Adjustable Lancing Device Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Blood Glucose Monitoring Lancing Device include Roche, Lifescan, Abbott, Ascensia, B. Braun, TERUMO, Sinocare, ARKRAY and GMMC Group, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Blood Glucose Monitoring Lancing Device manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Glucose Monitoring Lancing Device Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Blood Glucose Monitoring Lancing Device Market Segment Percentages, by Type, 2022 (%)
Adjustable Lancing Device
Non-adjustable Lancing Device
Global Blood Glucose Monitoring Lancing Device Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Blood Glucose Monitoring Lancing Device Market Segment Percentages, by Application, 2022 (%)
Online
Offline
Global Blood Glucose Monitoring Lancing Device Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (Units)
Global Blood Glucose Monitoring Lancing Device Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Glucose Monitoring Lancing Device revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blood Glucose Monitoring Lancing Device revenues share in global market, 2022 (%)
Key companies Blood Glucose Monitoring Lancing Device sales in global market, 2018-2023 (Estimated), (Units)
Key companies Blood Glucose Monitoring Lancing Device sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Lifescan
Abbott
Ascensia
B. Braun
TERUMO
Sinocare
ARKRAY
GMMC Group
BIONIME
LIANFA
Lobeck Medical AG
